Neglected tropical diseases

N Feasey, M Wansbrough-Jones… - British medical …, 2010 - academic.oup.com
Introduction The neglected tropical diseases (NTDs) are infectious diseases that principally
impact the world's poorest people. They have been neglected for decades, initially as part of …

[HTML][HTML] Social and economic burden of human leishmaniasis

I Okwor, J Uzonna - The American journal of tropical medicine and …, 2016 - ncbi.nlm.nih.gov
Leishmaniasis continues to pose a major public health problem worldwide. With new
epidemics occurring in endemic areas and the spread of the disease to previously free …

[PDF][PDF] Mental health of people with neglected tropical diseases: towards a person-centred approach

World Health Organization - 2020 - apps.who.int
neglected tropical diseases Page 1 WHO | 2020 Towards a person-centred approach Mental health
of people with neglected tropical diseases Page 2 Page 3 Mental health of people with neglected …

Whole genome sequencing of multiple Leishmania donovani clinical isolates provides insights into population structure and mechanisms of drug resistance

T Downing, H Imamura, S Decuypere, TG Clark… - Genome …, 2011 - genome.cshlp.org
Visceral leishmaniasis is a potentially fatal disease endemic to large parts of Asia and Africa,
primarily caused by the protozoan parasite Leishmania donovani. Here, we report a high …

[HTML][HTML] Single-dose liposomal amphotericin B for visceral leishmaniasis in India

S Sundar, J Chakravarty, D Agarwal… - … England Journal of …, 2010 - Mass Medical Soc
Background Some 50% of patients with visceral leishmaniasis (kala-azar) worldwide live in
the Indian state of Bihar. Liposomal amphotericin B is an effective treatment when …

Combination therapy for visceral leishmaniasis

J van Griensven, M Balasegaram, F Meheus… - The Lancet infectious …, 2010 - thelancet.com
Combination therapy for the treatment of visceral leishmaniasis has increasingly been
advocated as a way to increase treatment efficacy and tolerance, reduce treatment duration …

Why miltefosine—a life-saving drug for leishmaniasis—is unavailable to people who need it the most

T Sunyoto, J Potet, M Boelaert - BMJ global health, 2018 - gh.bmj.com
Miltefosine, the only oral drug approved for the treatment of leishmaniasis—a parasitic
disease transmitted by sandflies—is considered as a success story of research and …

Continuing challenge of infectious diseases in India

TJ John, L Dandona, VP Sharma, M Kakkar - The Lancet, 2011 - thelancet.com
In India, the range and burden of infectious diseases are enormous. The administrative
responsibilities of the health system are shared between the central (federal) and state …

Laboratory diagnostics for human Leishmania infections: a polymerase chain reaction-focussed review of detection and identification methods

I Gow, NC Smith, D Stark, J Ellis - Parasites & Vectors, 2022 - Springer
Leishmania infections span a range of clinical syndromes and impact humans from many
geographic foci, but primarily the world's poorest regions. Transmitted by the bite of a female …

Defining research to improve health systems

JHF Remme, T Adam, F Becerra-Posada… - PLoS …, 2010 - journals.plos.org
Defining Research to Improve Health Systems | PLOS Medicine Skip to main content
Advertisement PLOS Medicine Browse Current Issue Journal Archive Special Issues …